Search clinical trials for: 60 mg PRAX-114

Total 397 results

Idorsia Pharmaceuticals Ltd.

Completed

A Study to Investigate the Pharmacokinetics of ACT-1014-6470 in Subjects With Severe Renal Impairment Compared to Control Subjects

Healthy

Germany
UCB Japan Co. Ltd.

Completed

Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy

Rheumatoid Arthritis

Japan, Korea, Republic of, Taiwan
Enteris BioPharma Inc.
Syneos Health; Parexel

Recruiting

Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis

Endometriosis

United States
Myanmar Oxford Clinical Research Unit
Medical Action Myanmar; Myanmar Liver Foundation

Withdrawn

Hepatitis C Treatment Study in Myanmar

Hepatitis C

Myanmar
H. Lundbeck A/S

Completed

Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease (STAR Extension)

Alzheimer's Disease

Germany, United States, Argentina, Belgium, Brazil, Bulgaria, Canada, Chile, Croatia, Czechia, Denmark, Estonia, Finland, France, Hungary, Israel, Italy, Korea, Republic of, Lithuania, Poland, Portugal, Romania, South Africa, Spain, Taiwan and more
University of Ghana

Unknown

Fermented Iron-rich Supplement in Reducing Anemia (FISRA)

Iron Deficiency Anemia
Collegium Medicum w Bydgoszczy

Completed

Effectiveness of Lower Maintenance Dose of Ticagrelor Early After Myocardial Infarction (ELECTRA) Pilot Study

Myocardial Infarction

Poland
Healthgen Biotechnology Corp.

Recruiting

Study of OsrhAAT or Placebo in Healthy Volunteers

Emphysema Secondary to Congenital AATD

United States
Dong-A University

Completed

Prasugrel With Lower Dose - Loading Dose (PRELOAD-LD)

Coronary Artery Disease

Korea, Republic of
Auris Medical, Inc.

Terminated

Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment (ASSENT)

Hearing Loss, Idiopathic Sudden Sensorineural

United States, Korea, Republic of, Canada
SynAct Pharma Aps
NBCD A/S

Recruiting

A Dose-range Study of the Safety and Efficacy of Treatment in Adult Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate (RESOLVE)

Rheumatoid Arthritis

Moldova, Republic of
Estetra

Completed

E4/DRSP Single and Multiple Dose PK and Early QT Study

Contraception
HighField Biopharmaceuticals Corporation

Recruiting

A Clinical Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HF158K1 in Participants With HER-2 Positive or HER-2 Low Expression Advanced Solid Tumors

Solid Tumors, Adult

China, United States
University of Erlangen-Nürnberg Medical School
Merck Sharp & Dohme LLC; Rush University Medical Center; HELIOS Kliniken GmbH

Terminated

Modulation of the Surgical Inflammatory Response by Etoricoxib

Pain | Postoperative Pain | Osteoarthritis, Hip

Germany
GlaxoSmithKline
Hamell

Withdrawn

Risk Management Plan (RMP) Survey for Purchasers of Alli® (60 mg Orlistat) in the European Union.

Weight Loss
Tehran University of Medical Sciences
Shiraz University of Medical Sciences; Ahvaz Jundishapur University of Medical... and other collaborators

Completed

Treating Hepatitis C in CRF Using Sofosbuvir and Daclatasvir (SD-CRF)

Hepatitis C, Chronic | Chronic Renal Failure

Iran, Islamic Republic of
Dong-A University

Terminated

Prasugrel and Ticagrelor in ST-segment Elevation Myocardial Infarction

ST-Segment Elevation Myocardial Infarction

Korea, Republic of
Organon and Co

Completed

A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108)

Spondylitis, Ankylosing
Oswaldo Cruz Foundation
Universidade Federal de Pernambuco; World Health Organization

Completed

Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in Brazil

Schistosomiasis Mansoni
Chiesi Farmaceutici S.p.A.
ICON plc

Not yet recruiting

A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease (FLY)

Fabry Disease
University of Karachi
SAMI Pharmaceutical, Karachi Pakistan

Completed

Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects. (BABE)

Healthy | Bioequivalence Study

Pakistan
Auzone Biological Technology Pty Ltd
TIGERMED AUSTRALIA PTY LIMITED; CMAX Clinical Research Pty Ltd

Completed

A Study of TTYP01 in Healthy Adult Subjects

Healthy Adult Subjects

Australia
KeifeRx, LLC
Worldwide Clinical Trials; Life Molecular Imaging GmbH; Sun Pharmaceuticals Industries...

Not yet recruiting

Evaluating the Efficacy and Safety of Nilotinib BE in Subjects With Early Alzheimer's Disease (NILEAD)

Alzheimer Disease
Antengene Corporation

Active, not recruiting

A Study of Evaluating the Safety and Efficacy of ATG-010 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (SEARCH)

Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

China
Hoffmann-La Roche

Recruiting

Study to Investigate the Pharmacokinetics and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype. (Aldebaran)

Angelman Syndrome

Australia, United States, Spain, Italy, France, Germany
Takeda

Completed

A Study to Compare the Bioavailability (BA) of Dexlansoprazole Delayed-release Capsules

Healthy Volunteers

United States
Takeda

Completed

Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants

Healthy Volunteers

United States
Janssen R&D Ireland

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.

Healthy

United States
R-Pharm International, LLC
Data Management 365; K-Research, LLC

Completed

Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)

COVID-19

Russian Federation
Borstkanker Onderzoek Groep
Amgen

Withdrawn

Study to Identify the Impact of Denosumab on the Immune System in Patients With HER2 Negative Breast Cancer (PERIDENO)

Breast Neoplasms

Netherlands
Hospital Clinic of Barcelona

Recruiting

Effects of Ospemifene on Brain Activation Patterns in Women With Sexual Interest-arousal Disorders (EROS)

Vulvovaginal Signs and Symptoms | Genitourinary Syndrome of Menopause | Sexual; Disorder, Arousal, Female

Spain
Sanjay Gandhi Postgraduate Institute of Medical...

Completed

Safety of Sofosbuvir in People With Advanced Kidney Failure

Hepatitis C | Kidney Failure, Chronic

India
Amgen

Completed

A Randomized, Double-blind, Placebo-controlled, Dose Response Study of AMG 162 (Denosumab) in Japanese Postmenopausal Osteoporotic Subjects

Osteoporosis
Novartis Pharmaceuticals

Completed

Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications (Navigator)

Diabetes Mellitus, Type 2

Austria, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, Ecuador, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Italy, Malaysia, Mexico, Netherlands, Norway, Peru, Poland, Russian Federation and more
Ipsen

Completed

Somatuline Predictive Factors in Acromegaly and NET (SOPRANo)

Acromegaly | Neuroendocrine Tumours

Switzerland, Austria, Germany
Ipsen

Terminated

Predictive Factors Study (TAPAS)

Acromegaly

Australia
Praxis Precision Medicines

Recruiting

Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET)

Essential Tremor

United States
Medical College of Wisconsin

Completed

Pracinostat and Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Relapsed Adult AML

United States
George Washington University
Columbia University; Harvard School of Public Health (HSPH); Ifakara Health Institute and other collaborators

Not yet recruiting

Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial

Pregnancy Related
ConjuChem

Completed

A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Who Are Currently on Metformin Monotherapy

Type 2 Diabetes Mellitus

Canada
Radboud University Medical Center
Gilead Sciences

Completed

Relative Bioavailability Study to Investigate a Potential Interaction Between DTG DT and F/TAF TOS. (UNIVERSALRBA)

Hiv

Netherlands
Swiss Federal Institute of Technology

Completed

The Optimization of Iron Bioavailability of Supplements Using Hepcidin Levels in Humans

Iron Deficiency

Switzerland
Pfizer

Completed

Pharmacokinetics Of Azithromycin Immediate Release And Extended Release Formulation In Kids With Acute Otitis Media

Acute Otitis Media

Costa Rica
Boryung Pharmaceutical Co., Ltd

Completed

Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K) (Fimasartan)

Essential Hypertension
Actavis Inc.

Completed

A Relative Bioavailability Study of 60 mg Nifedipine ER Tablets Under Non-fasting Conditions

Healthy

United States
MedImmune LLC

Completed

Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis, Relapsing Forms

United States, Spain, Poland, Ukraine
Yonsei University

Completed

A Comparative Study of Salvage Treatment With Combination of Docetaxel and Epirubicin

Metastatic Advanced Gastric Cancer

Korea, Republic of
Pfizer

Completed

A Study Testing A Radioactive Compound Given Through A Vein With And Without The Non-Radioactive Compound, Given By Mouth, To Characterize Tissue Distribution Using Positron Emission Tomography Scanning

Healthy

United States
MedImmune LLC

Completed

A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL

Allergic Rhinitis | Healthy Volunteers | Atopic Dermatitis | Allergic Asthma

United States
Isofol Medical AB

Completed

PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer

Colonic Neoplasms

Sweden

3

Subscribe